SEROQUEL XR 50 mg/1 (Quetiapine TABLET, EXTENDED RELEASE) 50 mg/1

SEROQUEL XR 50 mg is an extended-release tablet containing quetiapine, used for managing certain mental health conditions. This medication is designed for oral administration and is manufactured by AstraZeneca Pharmaceuticals LP in the USA.

Strength

50 mg/1

Pack Size

60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0310-0280-60)

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

SEROQUEL XR 50 mg is primarily used for the treatment of schizophrenia and bipolar disorder. Quetiapine, the active ingredient, is often prescribed to help manage symptoms such as hallucinations, delusions, and mood swings. This extended-release formulation is designed to provide a steady release of the medication over time, which may help in maintaining consistent levels of the drug in the body.

Side Effects

Common effects of SEROQUEL XR 50 mg may include drowsiness, dizziness, and dry mouth. Some users may also experience weight gain or changes in appetite. These effects can vary from person to person and may diminish over time as the body adjusts to the medication.

Precautions & Warnings

SEROQUEL XR 50 mg should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should not be crushed or chewed, as it is designed for extended release.

Avoid Interactions

SEROQUEL XR 50 mg may interact with certain medications, including those that affect the central nervous system, such as alcohol and other antidepressants. It is also important to inform your healthcare provider about any other medications you are taking, including over-the-counter drugs and supplements, to avoid potential interactions.

Frequently Asked Questions

SEROQUEL XR 50 mg is used for managing symptoms of schizophrenia and bipolar disorder.

SEROQUEL XR 50 mg should be taken orally, typically once daily, and should not be crushed or chewed.

Common side effects may include drowsiness, dizziness, dry mouth, and weight gain.

It is important to consult a healthcare provider before taking SEROQUEL XR 50 mg with other medications to avoid potential interactions.

Yes, SEROQUEL XR is available in various strengths, including 50 mg, 150 mg, 200 mg, 300 mg, and 400 mg.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.